CDT Notes Sarborg Publication of PRISM Framework Expanding AI
CDT Equity Inc. (CDT)
Company Research
Source: GlobeNewswire
NAPLES, Fla. and CAMBRIDGE, United Kingdom, April 07, 2026 (GLOBE NEWSWIRE) -- CDT Equity Inc. (Nasdaq: CDT) (“CDT” or the “Company”), today notes the announcement from Sarborg Limited regarding the publication of its research paper titled “PRISM: cross-species connectivity mapping of plant intervention and stress signatures for translational agriculture.” CDT holds a 20% equity interest in Sarborg and believes this development represents a meaningful extension of Sarborg’s proprietary Signature Intelligence platform beyond its initial pharmaceutical focus into the agrichemical and broader industrial biology sectors. PRISM represents a novel framework for applying connectivity mapping to plant biology, enabling the systematic comparison of transcriptomic signatures across multiple species to identify functional relationships between interventions and stress responses. A copy of Sarborg’s full announcement is available at: Sarborg Publishes PRISM: A Cross-Species Connectivity Mapp
Show less
Read more
Impact Snapshot
Event Time:
CDT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CDT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CDT alerts
High impacting CDT Equity Inc. news events
Weekly update
A roundup of the hottest topics
CDT
News
- CDT Expands Multi-Pathway Value Creation Strategy Across Pharma, IP and AI-Driven DiscoveryGlobeNewswire
- CDT Equity Expands Tapinarof Intellectual Property Portfolio with Two New Patent FilingsGlobeNewswire
- CDT Equity Inc. Announces Reverse Stock SplitGlobeNewswire
- CDT Identifies Rare Disease Opportunities Through Sarborg Signature Analysis, Advancing Out-Licensing StrategyGlobeNewswire
- CDT Equity Stockholders Approve All Proposals at Special Meeting, Positioning the Company for Next Phase of Growth [Yahoo! Finance]Yahoo! Finance
CDT
Sec Filings
- 4/15/26 - Form 10-K
- 4/2/26 - Form 424B5
- 4/1/26 - Form NT
- CDT's page on the SEC website